- NSE
- AUROPHARMA
- BSE
- 524804
- ISIN
- INE406A01037
AUROPHARMA
₹1,578.80
−₹42.60 (−2.63%)
NSE close ·
AUROPHARMA closed at ₹1,578.80 on 21 Oct 2026, down 2.63% on the day, and is up 43.61% over the past year.
Price history
Between 23 Oct 2025 and 21 Oct 2026, the closing price ranged from ₹1,085.00 to ₹1,734.00.
Price returns, excl. dividends. 3Y, 5Y and Max are annualised.
Fundamentals
- P/E (TTM)
- 24.7
- EPS (TTM)
- ₹64.00
- Dividend yield
- 0.00%
EPS over the four quarters to 30 Jun 2026 (consolidated). Dividend yield is the past year’s dividends over the latest close.
Armor risk check
AUROPHARMA moves about 1.8× as much as the market
Volatility, past year
Worst fall, past year
Compared with the Nifty 500 over the past 12 months.
Check it against your portfolio in the appFAQs
What is AUROPHARMA's share price today?
AUROPHARMA (NSE: AUROPHARMA) closed at ₹1,578.80 on 21 Oct 2026, down 2.63% from the previous close of ₹1,621.40. It traded between ₹1,564.00 and ₹1,636.90 that day.
What are AUROPHARMA's 52-week high and low?
Over the last 52 weeks AUROPHARMA traded between ₹1,080.10 and ₹1,740.00, adjusted for splits and bonuses.
What are AUROPHARMA's NSE symbol, BSE code and ISIN?
AUROPHARMA has NSE symbol AUROPHARMA, BSE code 524804, ISIN INE406A01037.
How has AUROPHARMA performed over 1, 3 and 5 years?
AUROPHARMA's share price return: 1Y +43.61%, 3Y +22.15% a year, 5Y +17.47% a year. Dividends are not included.
Does AUROPHARMA pay a dividend?
Yes. AUROPHARMA's latest dividend went ex on 8 Aug 2025: Interim · ₹4.00 per share.
What is AUROPHARMA's P/E ratio?
AUROPHARMA's P/E ratio is 24.7: the ₹1,578.80 close on 21 Oct 2026 over trailing twelve-month EPS of ₹64.00 (consolidated, four quarters to 30 Jun 2026).
For information only. Not investment advice or a research report. Past performance does not guarantee future returns.
Full disclaimerSee how AUROPHARMA fits your plan
Armor checks every holding against your goals, risk and timeline.
Get the app